DBMB

Overview

DBMB is an inhibitor of spleen tyrosine kinase ( Syk ), capable of significantly inhibiting the activity of Syk kinase. DBMB exhibits anti-inflammatory activity by suppressing the signaling of NF-κB , which in turn reduces the production of inflammatory mediators such as nitric oxide ( NO ) and prostaglandin E2 ( PGE2 ). DBMB can be utilized in research on inflammatory diseases.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Syk | Products > Signaling Pathways > NO Synthase | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-169630
• CAS No.: 314027-66-2
• Molecular Formula: C24H22N4O
• Molecular Weight: 382.46
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source